Skip to main content
. 2019 May 6;12:601–611. doi: 10.2147/DMSO.S187422

Figure 3.

Figure 3

(A) Serum miR-509-5p relative expression pattern in different MetS groups compared to control group, (B) Serum miR-509-5p relative expression pattern in total MetS cases compared to control group.

Notes: *Significantly different from control subjects at p<0.05. **Significantly different from group 1 and 2 at p<0.05.